Toll-like receptor alterations in myelodysplastic syndrome

類似資料

• Clinical Effect of Point Mutations in Myelodysplastic Syndromes
  著者:: Bejar, Rafael, 等
  出版事項: (2011)
• Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
  著者:: Wei, Yue, 等
  出版事項: (2013)
• Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
  著者:: Bejar, Rafael, 等
  出版事項: (2012)
• Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes
  著者:: Dimicoli, Sophie, 等
  出版事項: (2013)
• Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome
  著者:: Dimicoli, Sophie, 等
  出版事項: (2011)